Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol
| Autor: | Rachel Kohn, Anil Vachani, Dylan Small, Alisa J. Stephens-Shields, Dorothy Sheu, Vanessa L. Madden, Brian A. Bayes, Marzana Chowdhury, Sadie Friday, Jannie Kim, Michael K. Gould, Mohamed H. Ismail, Beth Creekmur, Matthew A. Facktor, Charlotte Collins, Kristina K. Blessing, Christine M. Neslund-Dudas, Michael J. Simoff, Elizabeth R. Alleman, Leonard H. Epstein, Michael A. Horst, Michael E. Scott, Kevin G. Volpp, Scott D. Halpern, Joanna L. Hart, Andrea Ferris, George Fernandez, Amanda Holm, Sarah Evers-Casey, Benjamin Broder, Curt Hammock, Karen Yacobucci, M. Regina Clanton, Ryan Coffman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Pulmonary and Respiratory Medicine
Adult medicine.medical_specialty Lung Neoplasms medicine.medical_treatment media_common.quotation_subject Psychological intervention Vulnerable Populations law.invention Underserved Population Randomized controlled trial Acquired immunodeficiency syndrome (AIDS) law medicine Humans Early Detection of Cancer media_common Randomized Controlled Trials as Topic Clinical Study Design business.industry Smoking Abstinence medicine.disease Clinical trial Family medicine Smoking cessation Smoking Cessation business Lung cancer screening |
| Zdroj: | Ann Am Thorac Soc |
| Popis: | Smoking burdens are greatest among underserved patients. Lung cancer screening (LCS) reduces mortality among individuals at risk for smoking-associated lung cancer. Although LCS programs must offer smoking cessation support, the interventions that best promote cessation among underserved patients in this setting are unknown. This stakeholder-engaged, pragmatic randomized clinical trial will compare the effectiveness of four interventions promoting smoking cessation among underserved patients referred for LCS. By using an additive study design, all four arms provide standard “ask–advise–refer” care. Arm 2 adds free or subsidized pharmacologic cessation aids, arm 3 adds financial incentives up to $600 for cessation, and arm 4 adds a mobile device–delivered episodic future thinking tool to promote attention to long-term health goals. We hypothesize that smoking abstinence rates will be higher with the addition of each intervention when compared with arm 1. We will enroll 3,200 adults with LCS orders at four U.S. health systems. Eligible patients include those who smoke at least one cigarette daily and self-identify as a member of an underserved group (i.e., is Black or Latinx, is a rural resident, completed a high school education or less, and/or has a household income |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|